首页> 中文期刊> 《中国医学创新》 >美托洛尔治疗慢性心力衰竭的临床研究

美托洛尔治疗慢性心力衰竭的临床研究

             

摘要

目的:观察美托洛尔在慢性心衰中的应用效果。方法:将200例患者分为强化组和常规组,常规组采用常规治疗方法,强化组在此基础上并给予美托洛尔治疗。结果:强化组有效率87.0%,明显优于常规组71.0%。强化组患者治疗后的心率为(62.3±5.8)次/min,左心室射血量为(57.1±2.6)%;常规组患者治疗后的心率为(86.2±7.6)次/min,左心室射血量为(38.6±7.8)%。结论:慢性心衰在基础治疗中同时使用美托洛尔可获得更好的效果,安全性较好。%Objective: To investigate the application results of metoprolol in patients with chronic heart failure.Method:200 cases were randomly divided into intensive group and conventional group, the conventional group was treated by conventional treatment method. On this basis, the intensive group was given metoprolol. Result: The effective rate of the intensive group was 87.0%, which was more higher than that of the conventional group 71.0%. After treatment, the patient’s heart rate of the intensive group was (62.3±5.8) beats/min, left ventricular stroke volume was (57.1±2.6)%. Patient’s heart rate of the conventional group was (86.2±7.6) beats/min, left ventricular stroke volume was (38.6±7.8)%.Conclusion:On the basis of conventional therapy, patients with chronic heart failure will get better results, better security with metoprolol.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号